Xiaowei Dang
Impact in
- Hepatology top 5%
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
Papers in
- Hepatology 18
- Liver Disease and Transplantation 14
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Liver physiology and pathology 2
- Surgery 9
- Vascular anomalies and interventions 8
- Co-authors
- Penglei Ge (2 shared papers)Weiwei Wang (2 shared papers)Lin Li (2 shared papers)Yang Wu (2 shared papers)Gong Zhang (1 shared paper)Zhe Tang (1 shared paper)Zhiqiang Gao (1 shared paper)Xiu-Xian Ma (4 shared papers)
- Journals
- Aging (2 papers)Biomedicine & Pharmacotherapy (2 papers)Journal of Controlled Release (1 paper)Liver Transplantation (1 paper)World Journal of Clinical Oncology (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Xiaowei Dang
26 papers receiving 541 citations
Peers
Comparison fields: 5 of 57
- Hepatology 137
- Oncology 213
- Internal Medicine 21
- Cancer Research 76
- Immunology 39
Countries citing papers authored by Xiaowei Dang
This map shows the geographic impact of Xiaowei Dang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Dang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Dang more than expected).
Fields of papers citing papers by Xiaowei Dang
This network shows the impact of papers produced by Xiaowei Dang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Dang. The network helps show where Xiaowei Dang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaowei Dang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 181 | |
| 2 | 2019 | 111 | |
| 3 | Surgical treatment of 1360 cases of Budd-Chiari syndrome: 20-year experience. | 2004 | 37 |
| 4 | 2020 | 27 | |
| 5 | 2021 | 25 | |
| 6 | 2024 | 23 | |
| 7 | 2022 | 18 | |
| 8 | Treatment of membranous Budd-Chiari syndrome: analysis of 480 cases. | 2004 | 16 |
| 9 | 2019 | 15 | |
| 10 | 2022 | 15 | |
| 11 | Relations of Budd-Chiari syndrome to prothrombin gene mutation. | 2004 | 13 |
| 12 | 2011 | 12 | |
| 13 | 2020 | 11 | |
| 14 | Research status of Budd-Chiari syndrome in China. | 2014 | 9 |
| 15 | Studies on Budd-chiari syndrome complicated with hepatocellular carcinoma: most patients without inferior vena cava obstruction. | 2015 | 8 |
| 16 | 2019 | 8 | |
| 17 | 2023 | 8 | |
| 18 | Radical resection of pathological membrane for Budd-Chiari syndrome. | 2007 | 7 |
| 19 | Diagnosis and management of severe Budd-Chiari syndrome. | 2003 | 5 |
| 20 | 2019 | 5 |
About Xiaowei Dang
Xiaowei Dang is a scholar working on Hepatology, Surgery, Oncology, Internal Medicine and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 564 indexed citations. Recurring topics across this work include Liver Disease and Transplantation (14 papers), Vascular anomalies and interventions (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Liver physiology and pathology (2 papers), Immune cells in cancer (2 papers), Nanoplatforms for cancer theranostics (2 papers) and Venous Thromboembolism Diagnosis and Management (2 papers). The work is most often cited by research in Hepatology (137 citations), Oncology (213 citations), Internal Medicine (21 citations), Cancer Research (76 citations) and Immunology (39 citations). Xiaowei Dang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Penglei Ge, Weiwei Wang, Lin Li, Yang Wu, Gong Zhang, Zhe Tang, Zhiqiang Gao, Xiu-Xian Ma, Xueli Bai and Ting Liang. Their work appears in journals such as Aging, Biomedicine & Pharmacotherapy, Journal of Controlled Release, Liver Transplantation and World Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.